Factors associated with PSA testing in men ≥ 50 years in Ireland
Background Ireland has among the highest rates of prostate cancer in the EU, primarily due to widespread PSA screening. PSA screening is not recommended for asymptomatic men. Due to the potential for harm to the patient, and the economic and clinical repercussions for the healthcare system caused by...
Gespeichert in:
| Veröffentlicht in: | European journal of public health 2021-10, Vol.31 (Supplement_3) |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | Supplement_3 |
| container_start_page | |
| container_title | European journal of public health |
| container_volume | 31 |
| creator | O'Donovan, R Fitzpatrick, P |
| description | Background
Ireland has among the highest rates of prostate cancer in the EU, primarily due to widespread PSA screening. PSA screening is not recommended for asymptomatic men. Due to the potential for harm to the patient, and the economic and clinical repercussions for the healthcare system caused by inappropriate screening, this study aimed to investigate associations between PSA screening and sociodemographic, lifestyle, and health-related factors in men ≥50 years in Ireland.
Methods
A cross-sectional study was completed using data from Wave 4 of The Irish Longitudinal Study on Aging (TILDA), a nationally representative sample of community dwellers ≥ 50 years in Ireland. Participants self-reported having or not having a PSA test to screen for prostate cancer in the previous two years. Variables were entered into a multivariable logistic regression to estimate adjusted odds ratios (OR) for associations between PSA testing and the factors of interest.
Results
There were 2,426 male participants, with 68% reporting a PSA test in the previous two years. In adjusted analysis, older age (OR 1.78, 95%CI 1.32-2.31), third level education (OR 1.34, 95%CI 1.07-1.69) and a higher household net income (OR 2.14, 95% CI 1.52-3.02) increased the likelihood of PSA testing. Health-related factors positively associated with PSA testing screening were private health insurance (OR 1.89, 95%CI 1.52-2.35), blood pressure measurement in the previous year (OR 8.80, 95%CI 6.06-12.77) and a positive family history of cancer (OR 1.42, 95%CI 1.13-1.78).
Conclusions
High rates of prostate cancer screening are taking place in Ireland, despite the absence of a population-based screening programme. Men of older age, higher socioeconomic status and who demonstrate health-protective-behaviours have an increased risk of PSA screening. This subgroup of the population should be targeted to increase awareness of the potential benefits and harms of PSA testing.
Key messages
Rates of PSA screening remain high in Ireland, despite the absence of a population-based screening programme.
Increased awareness of the potential harms and benefits of PSA screening is needed. |
| doi_str_mv | 10.1093/eurpub/ckab165.143 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_TOX</sourceid><recordid>TN_cdi_proquest_journals_2597254194</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/eurpub/ckab165.143</oup_id><sourcerecordid>2597254194</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1533-f6c156fbedd220f8bab607b14fb8e6a53a26676da4437e356752382496f7701b3</originalsourceid><addsrcrecordid>eNqNkF9KAzEQh4MoWKsX8Cng87b5O9l9rMVqoaCggm8h2U10a7tbk12kR_AgXsyTGNkewKcZhu83M3wIXVIyoaTgU9eHXW-n5buxFOSECn6ERlSAyDiQl-PUU0IzyoCdorMY14QQqXI2QtcLU3ZtiNjE2Ja16VyFP-vuDT88znDnYlc3r7hu8NY1-OfrG0uC984kPs2WwW1MU52jE2820V0c6hg9L26e5nfZ6v52OZ-tspJKzjMPqYK3rqoYIz63xgJRlgpvcwdGcsMAFFRGCK4cl6Ak4zkTBXilCLV8jK6GvbvQfvTpNb1u-9Ckk5rJQjEpaCESxQaqDG2MwXm9C_XWhL2mRP-50oMrfXClk6sUyoZQ2-_-w_8CnX9teA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2597254194</pqid></control><display><type>article</type><title>Factors associated with PSA testing in men ≥ 50 years in Ireland</title><source>Oxford Journals Open Access Collection</source><creator>O'Donovan, R ; Fitzpatrick, P</creator><creatorcontrib>O'Donovan, R ; Fitzpatrick, P</creatorcontrib><description>Background
Ireland has among the highest rates of prostate cancer in the EU, primarily due to widespread PSA screening. PSA screening is not recommended for asymptomatic men. Due to the potential for harm to the patient, and the economic and clinical repercussions for the healthcare system caused by inappropriate screening, this study aimed to investigate associations between PSA screening and sociodemographic, lifestyle, and health-related factors in men ≥50 years in Ireland.
Methods
A cross-sectional study was completed using data from Wave 4 of The Irish Longitudinal Study on Aging (TILDA), a nationally representative sample of community dwellers ≥ 50 years in Ireland. Participants self-reported having or not having a PSA test to screen for prostate cancer in the previous two years. Variables were entered into a multivariable logistic regression to estimate adjusted odds ratios (OR) for associations between PSA testing and the factors of interest.
Results
There were 2,426 male participants, with 68% reporting a PSA test in the previous two years. In adjusted analysis, older age (OR 1.78, 95%CI 1.32-2.31), third level education (OR 1.34, 95%CI 1.07-1.69) and a higher household net income (OR 2.14, 95% CI 1.52-3.02) increased the likelihood of PSA testing. Health-related factors positively associated with PSA testing screening were private health insurance (OR 1.89, 95%CI 1.52-2.35), blood pressure measurement in the previous year (OR 8.80, 95%CI 6.06-12.77) and a positive family history of cancer (OR 1.42, 95%CI 1.13-1.78).
Conclusions
High rates of prostate cancer screening are taking place in Ireland, despite the absence of a population-based screening programme. Men of older age, higher socioeconomic status and who demonstrate health-protective-behaviours have an increased risk of PSA screening. This subgroup of the population should be targeted to increase awareness of the potential benefits and harms of PSA testing.
Key messages
Rates of PSA screening remain high in Ireland, despite the absence of a population-based screening programme.
Increased awareness of the potential harms and benefits of PSA screening is needed.</description><identifier>ISSN: 1101-1262</identifier><identifier>EISSN: 1464-360X</identifier><identifier>DOI: 10.1093/eurpub/ckab165.143</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Aging ; Blood pressure ; Cancer screening ; Cross-sectional studies ; Genetics ; Health care ; Health care industry ; Health insurance ; Longitudinal studies ; Medical screening ; Men ; Pressure measurement ; Prostate cancer ; Public health ; Socioeconomic status ; Socioeconomics ; Subgroups</subject><ispartof>European journal of public health, 2021-10, Vol.31 (Supplement_3)</ispartof><rights>The Author(s) 2021. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved. 2021</rights><rights>The Author(s) 2021. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1598,27845,27903,27904</link.rule.ids><linktorsrc>$$Uhttps://dx.doi.org/10.1093/eurpub/ckab165.143$$EView_record_in_Oxford_University_Press$$FView_record_in_$$GOxford_University_Press</linktorsrc></links><search><creatorcontrib>O'Donovan, R</creatorcontrib><creatorcontrib>Fitzpatrick, P</creatorcontrib><title>Factors associated with PSA testing in men ≥ 50 years in Ireland</title><title>European journal of public health</title><description>Background
Ireland has among the highest rates of prostate cancer in the EU, primarily due to widespread PSA screening. PSA screening is not recommended for asymptomatic men. Due to the potential for harm to the patient, and the economic and clinical repercussions for the healthcare system caused by inappropriate screening, this study aimed to investigate associations between PSA screening and sociodemographic, lifestyle, and health-related factors in men ≥50 years in Ireland.
Methods
A cross-sectional study was completed using data from Wave 4 of The Irish Longitudinal Study on Aging (TILDA), a nationally representative sample of community dwellers ≥ 50 years in Ireland. Participants self-reported having or not having a PSA test to screen for prostate cancer in the previous two years. Variables were entered into a multivariable logistic regression to estimate adjusted odds ratios (OR) for associations between PSA testing and the factors of interest.
Results
There were 2,426 male participants, with 68% reporting a PSA test in the previous two years. In adjusted analysis, older age (OR 1.78, 95%CI 1.32-2.31), third level education (OR 1.34, 95%CI 1.07-1.69) and a higher household net income (OR 2.14, 95% CI 1.52-3.02) increased the likelihood of PSA testing. Health-related factors positively associated with PSA testing screening were private health insurance (OR 1.89, 95%CI 1.52-2.35), blood pressure measurement in the previous year (OR 8.80, 95%CI 6.06-12.77) and a positive family history of cancer (OR 1.42, 95%CI 1.13-1.78).
Conclusions
High rates of prostate cancer screening are taking place in Ireland, despite the absence of a population-based screening programme. Men of older age, higher socioeconomic status and who demonstrate health-protective-behaviours have an increased risk of PSA screening. This subgroup of the population should be targeted to increase awareness of the potential benefits and harms of PSA testing.
Key messages
Rates of PSA screening remain high in Ireland, despite the absence of a population-based screening programme.
Increased awareness of the potential harms and benefits of PSA screening is needed.</description><subject>Aging</subject><subject>Blood pressure</subject><subject>Cancer screening</subject><subject>Cross-sectional studies</subject><subject>Genetics</subject><subject>Health care</subject><subject>Health care industry</subject><subject>Health insurance</subject><subject>Longitudinal studies</subject><subject>Medical screening</subject><subject>Men</subject><subject>Pressure measurement</subject><subject>Prostate cancer</subject><subject>Public health</subject><subject>Socioeconomic status</subject><subject>Socioeconomics</subject><subject>Subgroups</subject><issn>1101-1262</issn><issn>1464-360X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>7TQ</sourceid><recordid>eNqNkF9KAzEQh4MoWKsX8Cng87b5O9l9rMVqoaCggm8h2U10a7tbk12kR_AgXsyTGNkewKcZhu83M3wIXVIyoaTgU9eHXW-n5buxFOSECn6ERlSAyDiQl-PUU0IzyoCdorMY14QQqXI2QtcLU3ZtiNjE2Ja16VyFP-vuDT88znDnYlc3r7hu8NY1-OfrG0uC984kPs2WwW1MU52jE2820V0c6hg9L26e5nfZ6v52OZ-tspJKzjMPqYK3rqoYIz63xgJRlgpvcwdGcsMAFFRGCK4cl6Ak4zkTBXilCLV8jK6GvbvQfvTpNb1u-9Ckk5rJQjEpaCESxQaqDG2MwXm9C_XWhL2mRP-50oMrfXClk6sUyoZQ2-_-w_8CnX9teA</recordid><startdate>20211020</startdate><enddate>20211020</enddate><creator>O'Donovan, R</creator><creator>Fitzpatrick, P</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7TQ</scope><scope>C1K</scope><scope>DHY</scope><scope>DON</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20211020</creationdate><title>Factors associated with PSA testing in men ≥ 50 years in Ireland</title><author>O'Donovan, R ; Fitzpatrick, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1533-f6c156fbedd220f8bab607b14fb8e6a53a26676da4437e356752382496f7701b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aging</topic><topic>Blood pressure</topic><topic>Cancer screening</topic><topic>Cross-sectional studies</topic><topic>Genetics</topic><topic>Health care</topic><topic>Health care industry</topic><topic>Health insurance</topic><topic>Longitudinal studies</topic><topic>Medical screening</topic><topic>Men</topic><topic>Pressure measurement</topic><topic>Prostate cancer</topic><topic>Public health</topic><topic>Socioeconomic status</topic><topic>Socioeconomics</topic><topic>Subgroups</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>O'Donovan, R</creatorcontrib><creatorcontrib>Fitzpatrick, P</creatorcontrib><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>PAIS Index</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PAIS International</collection><collection>PAIS International (Ovid)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>European journal of public health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>O'Donovan, R</au><au>Fitzpatrick, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Factors associated with PSA testing in men ≥ 50 years in Ireland</atitle><jtitle>European journal of public health</jtitle><date>2021-10-20</date><risdate>2021</risdate><volume>31</volume><issue>Supplement_3</issue><issn>1101-1262</issn><eissn>1464-360X</eissn><abstract>Background
Ireland has among the highest rates of prostate cancer in the EU, primarily due to widespread PSA screening. PSA screening is not recommended for asymptomatic men. Due to the potential for harm to the patient, and the economic and clinical repercussions for the healthcare system caused by inappropriate screening, this study aimed to investigate associations between PSA screening and sociodemographic, lifestyle, and health-related factors in men ≥50 years in Ireland.
Methods
A cross-sectional study was completed using data from Wave 4 of The Irish Longitudinal Study on Aging (TILDA), a nationally representative sample of community dwellers ≥ 50 years in Ireland. Participants self-reported having or not having a PSA test to screen for prostate cancer in the previous two years. Variables were entered into a multivariable logistic regression to estimate adjusted odds ratios (OR) for associations between PSA testing and the factors of interest.
Results
There were 2,426 male participants, with 68% reporting a PSA test in the previous two years. In adjusted analysis, older age (OR 1.78, 95%CI 1.32-2.31), third level education (OR 1.34, 95%CI 1.07-1.69) and a higher household net income (OR 2.14, 95% CI 1.52-3.02) increased the likelihood of PSA testing. Health-related factors positively associated with PSA testing screening were private health insurance (OR 1.89, 95%CI 1.52-2.35), blood pressure measurement in the previous year (OR 8.80, 95%CI 6.06-12.77) and a positive family history of cancer (OR 1.42, 95%CI 1.13-1.78).
Conclusions
High rates of prostate cancer screening are taking place in Ireland, despite the absence of a population-based screening programme. Men of older age, higher socioeconomic status and who demonstrate health-protective-behaviours have an increased risk of PSA screening. This subgroup of the population should be targeted to increase awareness of the potential benefits and harms of PSA testing.
Key messages
Rates of PSA screening remain high in Ireland, despite the absence of a population-based screening programme.
Increased awareness of the potential harms and benefits of PSA screening is needed.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><doi>10.1093/eurpub/ckab165.143</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | ISSN: 1101-1262 |
| ispartof | European journal of public health, 2021-10, Vol.31 (Supplement_3) |
| issn | 1101-1262 1464-360X |
| language | eng |
| recordid | cdi_proquest_journals_2597254194 |
| source | Oxford Journals Open Access Collection |
| subjects | Aging Blood pressure Cancer screening Cross-sectional studies Genetics Health care Health care industry Health insurance Longitudinal studies Medical screening Men Pressure measurement Prostate cancer Public health Socioeconomic status Socioeconomics Subgroups |
| title | Factors associated with PSA testing in men ≥ 50 years in Ireland |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T06%3A23%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_TOX&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Factors%20associated%20with%20PSA%20testing%20in%20men%20%E2%89%A5%2050%20years%20in%20Ireland&rft.jtitle=European%20journal%20of%20public%20health&rft.au=O'Donovan,%20R&rft.date=2021-10-20&rft.volume=31&rft.issue=Supplement_3&rft.issn=1101-1262&rft.eissn=1464-360X&rft_id=info:doi/10.1093/eurpub/ckab165.143&rft_dat=%3Cproquest_TOX%3E2597254194%3C/proquest_TOX%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2597254194&rft_id=info:pmid/&rft_oup_id=10.1093/eurpub/ckab165.143&rfr_iscdi=true |